Raymond James Financial Inc. bought a new position in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH – Free Report) during ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Equities researchers at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for Zimmer Biomet in a report ...

Zimmer Biomet aims for 4% to 5% growth in orthopedics, driven by demographic trends and technological advancements. The company plans to regain market share in the hip category with new product ...

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products ...

please see the associated product Instructions For Use (IFU). Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.

Zimmer Biomet aims for 4% to 5% growth in orthopedics, driven by demographic trends and technological advancements. The company plans to regain market share in the hip category with new product ...

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of ...

Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches ...